Comparison of lipid levels in the diabetic and non diabetic patients: a study in a tertiary care hospital

Authors

  • Vydehi Veeramalla Department of Biochemistry, Anupama Hospital, KPHB Colony, Kukutpalli, Hyderabad, Telangana, India
  • Swetha Madas Department of TB and Chest, RVM Institute of Medical Sciences and Research Centre, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20175169

Keywords:

Coronary heart disease, Diabetes, Elevated lipid levels

Abstract

Background: The incidence of coronary artery diseases is 3 to 5 times higher in both male and female diabetic patients compared to general population. Individuals with diabetes may have several forms of dyslipidemia leading to additive cardiovascular risk of hyperglycemia. This study was therefore conducted to identify the levels of lipidemia in the diabetic patients in our area.

Methods: This study was conducted on 100 diabetic and 100 healthy patients, with 50 patients were males and 50 were females in both groups. Blood was collected in sodium fluoride tubes for all the patients for the estimation of glucose (both fasting and post prandial) and in serum tubes for lipids such as Triglycerides, Total cholesterol, High density cholesterol, Low density cholesterol and Very low density cholesterol.

Results: The total cholesterol among the males who were diabetic was in the normal range in 46% and high in 20% of the patients. Among the control, i.e. non diabetic patients, 76% of them had total cholesterol in the normal range and high cholesterol levels were observed in only 8% of them. The levels of triglycerides, total cholesterol and LDL were significantly higher in the patients with diabetes, compared to the non diabetic patients. HDL in these patients was significantly low.

Conclusions: The incidence of raised lipid levels in the diabetic patients is very high and since the elevated levels of lipids especially in these patients can lead to CHD and its complications, it is important for the monitoring of these levels throughout the course of the disease.

References

Abou-Seif MA, Youssef A. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta. 2004;346(2):161-70.

American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care. 2003;26(Suppl 1):S83-6.

Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975-80.

Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes. JAMA. 1990;263:2893-8.

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes. 2003;52:453-62.

Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141-6.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269(23):3015-23.

American Diabetes Association. Management of Dyslipidemia in Adults with Diabetes. Diabetes Care. 2002;25(suppl 1):s74-7.

Bhambhani GD, Bhambhani RG, Thakor NC. Lipid profile of patients with diabetes mellitus: a cross sectional study. Int J Res Med Sci. 2015;3:3292-5.

Ramachandran A. “Rising prevalence of diabetes in India and the implications of ADA – EASD consensus on the management” Chp 30. Singhal R K. Medicine update 2007;17:180-4.

Khan SR, Ayub N, Nawab S, Shamsi TS. Triglyceride profile in dyslipidemia of type 2 diabetes mellitus. J Coll Physicians Surg Pak. 2008;18(5):270-3.

Gadi R, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Curr Diabetes Rep. 2007;7(3):228-34.

Golay A. HDL metabolism in NIDDM measurement of HDL turn over using titrated HDL J. Clin Endocrinol Metab. 1987;65:512-8.

Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study. Diabetes Care. 1979;2(2):120-6.

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011.

Ahmad A, Khan AR, Raja ZA, Mustafa G. Measurement of serum cholesterol and triglyceride: evaluation in patients with diabetes, hypertension and cerebrovascular accidents in South Punjab. Professional. 2003;10(2):92-8.

Jain HR, Shetty V, Singh GS, Shetty S. A Study of Lipid Profile in Diabetes Mellitus. Int J Sci Stud 2016;4(9):56-61.

Singh G, Kumar AK. A Study of Lipid Profile in Type 2 Diabetic Punjabi Population. J Exercise Sci Physiotherapy. 2012;8(1):7-10.

Downloads

Published

2017-11-22

Issue

Section

Original Research Articles